Clinical Trial Update: Clozapine IM and Aggression in Schizophrenic Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intramuscular clozapine for aggression in schizophrenia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Clozapine IM (clozapine)

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Schizophrenia | Phase 3 | Status: WITHDRAWN